D&M Company Holds Study Session and Shares Materials on the FY2026 Medical Fee Revision – Niconico News

News Highlights

D&M Company conducted a study session and shared materials in preparation for the FY2026 medical fee revision. This initiative highlights the importance of mid-to-long-term management and business succession strategies, considering the revision cycle. Maintaining facility standards through economies of scale, dispersing the burden of capital investment, and utilizing tax schemes with an eye toward transitioning to specific or social medical corporations are also potential discussion points for preparing for the medical fee revision.

Perspective from M&A Medical Editorial Department

The study session held by D&M Company regarding the FY2026 medical fee revision underscores the need for strategic management decisions that go beyond mere information gathering. Particularly, considering that the revision cycle is every two years, it is essential to formulate management and succession plans that look 5 to 10 years ahead, rather than focusing on short-term responses. The economies of scale achieved through group formation will contribute to maintaining facility standards and dispersing the burden of high capital investment, thereby supporting the competitiveness of individual medical institutions. Furthermore, utilizing tax schemes such as transitioning to social medical corporations or specific medical corporations is key to improving profitability and ensuring sustainable business operations. This study session can serve as a catalyst for considering more advanced organizational restructuring and management strategies with future M&A and business succession in mind.

Discussion Points Indicated by This News

• The FY2026 medical fee revision will serve as an opportunity to formulate mid-to-long-term management and succession strategies.
• Economies of scale through group formation contribute to maintaining facility standards and dispersing capital investment burdens.
• Utilizing tax schemes with a view to transitioning to specific medical corporations or social medical corporations is important.
• Strategic preparation that considers the revision cycle is essential for maintaining the competitiveness of medical institutions.

Practical Questions Arising from This News

• What specific materials and discussion points were shared in this study session?
• What kind of group formation schemes is D&M Company proposing for medical institutions of what scale and specialties?
• What medical specialties or services are expected to be most significantly impacted by the FY2026 revision?

If You Feel “Should I Consult Too?”

Business owners and successors who feel uncertain about their institution’s management strategy or succession plan in preparation for the FY2026 medical fee revision should consider consulting with experts prompted by this news. In particular, to maintain future competitiveness and ensure smooth business succession, it is crucial to begin information gathering and deliberation early by collaborating with specialists such as M&A intermediaries and tax accountants regarding specific measures tailored to individual circumstances, such as economies of scale through group formation and the utilization of tax schemes.

M&A Medical (CentralMedience Inc.), as an M&A support institution certified by the Small and Medium Enterprise Agency, supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are handled with strict confidentiality. Free consultations available here.